The global nasal drug delivery technology market is projected to grow at a CAGR of approximately 7% over the next five years.

HIV is preventable, yet new diagnoses continue in AZ at higher-than-average rates. Could a new, twice-yearly shot called ...

SAN DIEGO, March 10, 2026 (GLOBE NEWSWIRE) -- ImageneBio, Inc. (Nasdaq: IMA) (“Imagene” or the “Company”) today reported financial results for the fourth quarter and full year ended December 31, 2025, ...

For Elizabeth Shikuku, health workers’ strikes used to mean a high risk of unplanned pregnancy. Now, a shift in national ...

Week Study Evaluating Subcutaneous VK2735 in Adults with Obesity and Type 2 Diabetes SAN DIEGO, March 26, 2026 /PRNewswire/ -- Viking Therapeutics, Inc. (Viking) ...

When we think about body fat, most of us focus on what we see in the mirror, the soft tissue we can pinch on our arms or waist. However, not all fat is created equal. Your body stores fat in two very ...

In the Phase 2 part of the AMETHYST study, litifilimab met the primary endpoint of reduction of disease activity in people living with CLE at Week 16, with more litifilimab participants achieving clea ...

Chief Financial Officer Andrew Dickinson told investors at the Barclays conference that the company is entering what he ...

There has been a n upsurge of interest, and some confusion, about the role of the connective tissue condensations within the lower limb ...